Validation of Innovative Scheimpflug Topography Derived RGP Contact Lens Designs In Optometry Network

NCT ID: NCT06312163

Last Updated: 2024-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-06

Study Completion Date

2023-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this Prospective, single-site, cohort study is to validate rigid gas permeable corneal contact lens (RGP) designs for keratoconus derived from combining the data from corneal topography scans and contact lenses ordered in patients with keratoconus (KC) attending a UK tertiary NHS Hospital contact lens clinic. The main questions it aims to answer are:

* Does a Scheimpflug topography derived RGP contact lens design for keratoconus have the equivalent overall contact lens fit as the patients' own lens?
* Is the number of trial lenses required to fit a patient is reduced compared to standard practice?
* Is the time taken to fit a contact lens is reduced compared to standard practice?
* Is there user acceptance of the new lens?
* Are the Axial ege lift (AEL) changes clinically significant?

There will be 3 work packages

WP1: For each participant data collection will take place over two visits.

• Visit 1: Pentacam topography scans and optimal 'virtual' lens selection will take place. • • Visit 2: Participants are fitted with 4 contact lenses (i) the optimal lens design as specified by the virtual fitting module, (ii) a contact lens with a clinically significant step flatter AEL (iii) a contact lens steeper in axial edge lift (AEL) (iv) the participant's own contact lens.

Each CL fit will be assessed with slit lamp photography according to the standardised method proposed by Wolffsohn et al. (2013), Anterior segment OCT MS39) (CSO Hansom Instruments, UK) and best-corrected visual acuity with each lens design using high-contrast logMAR .

WP2. Participants will attend one appointment where a traditional lens fit, and a lens fitted using the topography guided 'virtual' module will be undertaken (with the fitting method selected for each eye randomised). For each fitting method the total fitting time will be measured and the total number of trial contact lenses used. Patients will be invited to complete a questionnaire that probes their satisfaction of this process.

WP3. Clinicians not involved in the study will be invited to examine a demo version of the virtual fitting module and complete the validated system usability scale tool.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Keratoconus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ARM1

The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design)

The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.

Intervention Type DEVICE

The participants will be fitted with (i) the optimal lens design as specified by the virtual fitting module, in addition to (ii) lenses that are one clinically significant step (0.12 mm) flatter and (iii) steeper in axial edge lift (AEL).

Arm2

The patient's own corneal RGP lens - CE (UKCA) marked class 2 medical devices.

The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.

Intervention Type DEVICE

The participants will be fitted with (i) the optimal lens design as specified by the virtual fitting module, in addition to (ii) lenses that are one clinically significant step (0.12 mm) flatter and (iii) steeper in axial edge lift (AEL).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The contact lens to be investigated in this study (Scheimpflug topography derived corneal RGP contact lens design). A CE (UKCA) marked class 2 medical devices.

The participants will be fitted with (i) the optimal lens design as specified by the virtual fitting module, in addition to (ii) lenses that are one clinically significant step (0.12 mm) flatter and (iii) steeper in axial edge lift (AEL).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- WP1:
* (a) Presence of keratoconus in either eye
* (b) Currently using a rigid gas permeable contact lens correction
* (c) Male or female, aged 18 years or older
* (d) The absence of significant media opacities
* (e) No ocular pathology other than keratoconus
* (f) Ability to understand nature/purpose of the study and to provide informed consent
* (g) Ability to follow instructions and complete the study
* (h) Ability to speak English
* WP2:
* (a) Presence of keratoconus in both eyes
* (b) Male or female, aged 18 years or older
* (c) The absence of significant media opacities
* (d) No ocular pathology other than keratoconus
* (e) Ability to understand nature/purpose of the study and to provide informed consent
* (f) Ability to follow instructions and complete the study
* (g) Ability to speak English
* WP3:
* (a) Optometrist, dispensing optician or ophthalmologist registered with the General Optical Council
* (b) Works within contact lens service at Moorfields Eye Hospital
* (c) Ability to understand nature/purpose of the study and to provide informed consent
* (d) Ability to follow instructions and complete the study
* (e) Ability to speak English .

Exclusion Criteria

* \- WP1:
* (a) Any systemic disease likely to affect visual performance
* (b) Any ocular disease that may affect visual performance, other than keratoconus
* (c) Hearing impairment sufficient to interfere with hearing instructions
* (d) Poor understanding of English language and/or alphabet
* (e) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from
* complying with the required procedures, schedule, or other study conduct.
* (f) Not currently using a rigid gas permeable contact lens or a contraindication to this
* (g) A history of corneal graft surgery (keratoplasty) in the eye under investigation.
* (h) A recent history (in preceding 12 months) of corneal abrasions in the designated study eye
* (i) A recent history (in preceding 1 month) of corneal cross linking for keratoconus
* WP2:
* (a) Any systemic disease likely to affect visual performance
* (b) Any ocular disease that may affect visual performance, other than keratoconus
* (c) Hearing impairment sufficient to interfere with hearing instructions
* (d) Poor understanding of English language and/or alphabet
* (e) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from
* complying with the required procedures, schedule, or other study conduct.
* (f) A contraindication to rigid gas permeable contact lens wear
* (g) A history of corneal graft surgery (keratoplasty) in the eye under investigation.
* (h) A recent history (in preceding 12 months) of corneal abrasions in the either eye
* (i) A recent history (in preceding 1 month) of corneal cross linking for keratoconus
* WP3:
* (a) An optometrist dispensing optician or ophthalmologist not fully registered with the General Optical Council (e.g., a pre-registration optometrist)
* (b) Hearing impairment sufficient to interfere with hearing instructions
* (c) Poor understanding of English language and/or alphabet
* (d) Any condition which, in the investigator's opinion, would conflict or otherwise prevent the participant from complying with the required procedures, schedule, or other study conduct.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Moorfields Eye Hospital NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Moorfields Eye Hospital NHS Foundation Trust

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EHRD1001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Initial Correction Keratoconus
NCT04918316 ACTIVE_NOT_RECRUITING NA
Collagen Cross-linking in Keratoconus
NCT03760432 RECRUITING NA
Customized Contact Lenses
NCT05134909 UNKNOWN NA